SAMETTA SANYAOLU: Open Payments
NPI 1730695503 · GREENBELT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,422 in 421 payments from 35 companies in 2025. Trend: 2023 $8,627 · 2024 $8,100 · 2025 $8,422
Food & beverage: $8,065Education: $207Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 113 | $1,409 |
| Biogen, Inc. | 34 | $906 |
| PFIZER INC. | 40 | $777 |
| Teva Pharmaceuticals USA, Inc. | 17 | $684 |
| Axsome Therapeutics, Inc. | 23 | $473 |
| Amgen Inc. | 23 | $464 |
| ANI Pharmaceuticals, Inc. | 17 | $327 |
| Neurocrine BioSciences, Inc. | 11 | $324 |
| Vanda Pharmaceuticals Inc. | 10 | $319 |
| Lundbeck LLC | 20 | $263 |
Products named: TYSABRI, NURTEC ODT, UBRELVY, QULIPTA, AUSTEDO XR, UPLIZNA, Symbravo, PURIFIED CORTROPHIN GEL.
Industry payments across MD — which companies pay providers there.
